Oncology Drug Forecasting: Managing the Complexities

Hotel Sofitel New York, New York 

Tuesday, September 9, 2008

 

Organizations must address the complexities of assessing the market potential for new and existing systemic therapies used in a myriad of tumor types.  As a result, there are a number of common questions oncology companies need to answer.

  • What is the commercial potential for our product if we can secure reimbursement for stage IV squamous NSCLC patients? 

  • How will therapy selection by KRAS genotype affect the target patient population for our new metastatic colorectal cancer drug?

  • How many patients could potentially be treated with our supportive care drug across all tumor types in each major market in the world?

 These questions and others will be answered by focusing on:

  • Challenges in Oncology forecasting

  • Trends in Oncology services in light of key factors which could affect demand

  • The role of guidelines and their impact on demand

  • Bringing reality into forecasting oncology drugs

  • Projecting the population of cancer patient subsets

Ideal candidates for this seminar include:

  • Marketing Professionals

  • Market Research Professionals

  • Business Development Professionals

  • Clinical Research Professionals

  • Financial and Biotech Analysts

The cost for this conference is $250 per participant.  

or

  • Download the PDF below and complete page 3 and fax to 905-823-5955

 

Click the 'Buy Now' option below to pay for the conference with a credit card using PayPal

 

 

Contact Information: 

Strategic Answers Inc. 48 Wilgar Road, Toronto, Ontario

Phone: 416-604-4043 Fax: 905-823-5955

E-Mail: Contact@StrategicAnswers.com